CytoSorbents Corporation (CTSO)

[ping_pow_princess]

It's pretty clear to me, "To your other question about patient data, we have stated that we will use the first 22 patients out of our targeted 100 patients for mainly safety. Efficacy data for both cytokines and clinical endpoints will come from the subsequent 78 patients." but I think he was talking about how the data will be submitted for CE Mark application and not data for trial reporting.

Anyway, we shall see soon because results should be out sometime in September.